BPC-157
Gastric-derived pentadecapeptide studied for VEGFR2-mediated angiogenesis and tissue repair.
This product is not a drug, food, or cosmetic and is not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use. By purchasing, you confirm you are a qualified researcher or institution acquiring this product solely for in-vitro laboratory research. See our Research Disclaimer for full terms.
Description
BPC-157 is a synthetic pentadecapeptide derived from a partial sequence found in human gastric juice. Its best-characterized research mechanism is upregulation of VEGFR2 signaling, activating the Akt-eNOS pathway to promote endothelial tube formation and blood-flow recovery in ischemic tissue models, alongside FAK-paxillin pathway activity relevant to cell migration. Most supporting data remains preclinical; no regulatory agency has approved BPC-157 for any indication. Supplied for in-vitro laboratory research only — not for human or veterinary use.